
Xtrackers MSCI World Health Care UCITS ETF
Xtrackers MSCI World Health Care UCITS ETF (XDWHF) Price & Chart
XDWHF ETF Chart & Stats
- Day’s Range
- $66.01 - $66.01
- 52-Week Range
- $55.39 - $66.01
- Previous Close
- $66.01
- Volume
- 0
- Average Volume (3M)
- 1,536
- AUM
- 4.64B
- NAV
- 68.70
- Expense Ratio
- 0.26%
- Holdings Count
- 114
- Beta
- -0.18
- Inception Date
- Nov 22, 2010
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 65,317,530
- Standard Deviation
- N/A
ETF Overview
Xtrackers MSCI World Health Care UCITS ETF
The Xtrackers MSCI World Health Care UCITS ETF (Ticker: XDWHF) offers investors a strategic gateway into the dynamic and essential Health Care sector on a global scale. This exchange-traded fund (ETF) is meticulously designed to track the performance of the MSCI World Health Care Index, providing exposure to a diversified portfolio of leading health care companies worldwide. As a sector-focused ETF, XDWHF targets the burgeoning health care industry, capturing the growth potential of pharmaceutical giants, innovative biotech firms, pioneering medical device manufacturers, and comprehensive health service providers. Situated within the broad-based niche of global health care investments, this ETF offers an attractive proposition for investors seeking to capitalize on the increasing demand for health care services and products driven by demographic shifts and technological advancements. By investing in XDWHF, investors gain access to a vital sector that not only plays a crucial role in everyday life but also holds significant growth potential due to ongoing innovation and the rising importance of health and wellness in society. Ideal for those looking to diversify their portfolio with a focus on health care, XDWHF provides a robust, cost-effective solution with the liquidity and transparency that only an ETF can offer. Whether you're a seasoned investor or new to the market, the Xtrackers MSCI World Health Care UCITS ETF is a compelling choice for anyone looking to align their investment strategy with the future of global health care.
- Asset Class
- Equity
- Region
- Developed Markets
- Issuer
- Xtrackers
- Index Tracked
- MSCI World Index / Health Care -SEC
- Ticker Symbol
- XDWHF
XDWHF ETF News


Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie’s official study, “A Post-marketing Non-interventional Study for Upadacitinib in Patients With Moderately to Severely Active Crohn’s Disease











